We are live on ! Find out more
MXCT icon

MaxCyte
MXCT

120 hedge funds and large institutions have $331M invested in MaxCyte in 2023 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 49 increasing their positions, 30 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

65% more capital invested

Capital invested by funds: $201M → $331M (+$130M)

63% more repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 30

5.74% more ownership

Funds ownership: 62.17% → 67.91% (+5.7%)

0% more funds holding

Funds holding: 120 → 120 (0)

0% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 20

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $21K

Holders
120
Holders Change
–
Holders Change %
0%
% of All Funds
1.75%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.04%
New
20
Increased
49
Reduced
30
Closed
20
Calls
–
Puts
$21K
Net Calls
-$21K
Net Calls Change
+$7K

Top Buyers

1
CCM
Cadian Capital Management
New York
+$22M
2
Morgan Stanley
Morgan Stanley
New York
+$21.9M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$11M
4
Millennium Management
Millennium Management
New York
+$4.54M
5
PCM
Portolan Capital Management
Massachusetts
+$2.39M

Top Sellers

1
SCM
Stonepine Capital Management
Oregon
-$11.7M
2
Holocene Advisors
Holocene Advisors
New York
-$6.61M
3
American Century Companies
American Century Companies
Missouri
-$6.32M
4
CC
Casdin Capital
New York
-$5.9M
5
ACH
ArrowMark Colorado Holdings
Colorado
-$4.03M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$1.79M +$165K +42,459 +13%
Lazard Asset Management
27
Lazard Asset Management
New York
$1.73M -$351K -90,236 -20%
RA
28
Royce & Associates
New York
$1.54M -$371K -95,222 -23%
AMH
29
Apollo Management Holdings
New York
$1.45M – – –
Allspring Global Investments
30
Allspring Global Investments
North Carolina
$1.37M -$140K -35,862 -11%
RG
31
Rathbones Group
United Kingdom
$1.35M -$10.6K -2,730 -0.9%
William Blair & Company
32
William Blair & Company
Illinois
$1.2M +$10.6K +2,712 +1%
Jacobs Levy Equity Management
33
Jacobs Levy Equity Management
New Jersey
$1.18M +$977K +251,001 New
N
34
Nuveen
North Carolina
$1.17M +$9.1K +2,337 +1%
Charles Schwab
35
Charles Schwab
California
$1.15M +$20.5K +5,271 +2%
JP Morgan Chase
36
JP Morgan Chase
New York
$1.13M -$456K -117,148 -33%
BL
37
Bleichroeder LP
New York
$1.12M – – –
Goldman Sachs
38
Goldman Sachs
New York
$928K +$56K +14,392 +8%
Renaissance Technologies
39
Renaissance Technologies
New York
$889K -$85.7K -22,000 -10%
Swiss National Bank
40
Swiss National Bank
Switzerland
$815K -$65.8K -16,900 -9%
Two Sigma Investments
41
Two Sigma Investments
New York
$716K +$593K +152,360 New
UBS AM
42
UBS AM
Illinois
$695K – – –
Bank of America
43
Bank of America
North Carolina
$683K +$226K +58,015 +67%
Barclays
44
Barclays
United Kingdom
$648K +$414K +106,266 +337%
AIMCA
45
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$640K -$248K -63,688 -32%
Citadel Advisors
46
Citadel Advisors
Florida
$635K +$339K +86,981 +181%
RhumbLine Advisers
47
RhumbLine Advisers
Massachusetts
$624K +$5.62K +1,443 +1%
Bank of Montreal
48
Bank of Montreal
Ontario, Canada
$606K +$3.64K +935 New
SO
49
STRS Ohio
Ohio
$540K -$24.5K -6,300 -5%
Squarepoint
50
Squarepoint
New York
$523K +$434K +111,375 New
1
2
3 4 5

MXCT Hedge Fund Activity: Q4 2023 in Review

120 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in MaxCyte (MXCT) for Q4 2023, worth a combined $331M — up 65% from $201M a quarter earlier.

Fund positioning in MXCT was balanced in Q4 2023: 20 funds opened new positions, 20 closed out, 49 added to existing stakes and 30 trimmed.

The largest buyer was Cadian Capital Management, opening a new position worth an estimated $22M. The largest seller was Stonepine Capital Management, exiting entirely with an estimated $11.7M sold.

  • 120 institutional investors held MaxCyte (MXCT) as of Q4 2023, unchanged from Q3 2023.
  • Funds reported $331M of MaxCyte stock for Q4 2023, up 65% quarter-over-quarter.
  • 20 funds opened new MaxCyte positions in Q4 2023 and 20 closed out, a net change of 0 holders.
  • The largest MaxCyte buyer in Q4 2023 was Cadian Capital Management, an estimated $22M added.
  • The largest MaxCyte seller in Q4 2023 was Stonepine Capital Management, an estimated $11.7M sold.

Based on aggregated 13F filings for Q4 2023.